XRCC2 and ovarian cancer: To date, our findings display the expression level and predictive value of XRCC2 in ovarian carcinoma, implying that XRCC2 might be a favorable prognostic indicator for ovarian cancer, particularly in patients with serous, poor-differentiated and late stage.